Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ODC1 | P11926 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.43 |
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA4 | P22748 | 3/20 | 0.43 |
| ▸ | CA6 | P23280 | 3/20 | 0.43 |
| ▸ | CA5A | P35218 | 3/20 | 0.43 |
| ▸ | CA7 | P43166 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA3 | P07451 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | CASP2 | P42575 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | F13A1 | P00488 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10606122 | 0.89 | DNM1 (0.53) | ODC1NFKB1DNM1CA12CA2 | |
| SCHEMBL9642847 | 0.89 | DNM1 (0.53) | ODC1NFKB1DNM1CA12CA2 | |
| SCHEMBL7770260 | 0.87 | ODC1 (0.45) | ODC1NFKB1DNM1CA12CA2 | |
| SCHEMBL1397430 | 0.85 | ODC1 (0.50) | ODC1NFKB1DNM1CA12CA2 | |
| SCHEMBL27888436 | 0.85 | DNM1 (0.57) | ODC1NFKB1DNM1CA12CA2 | |
| SCHEMBL16645096 | 0.84 | — | — | |
| SCHEMBL3233341 | 0.84 | ODC1 (0.43) | ODC1NFKB1DNM1CA12CA2 | |
| SCHEMBL91297 | 0.84 | — | — | |
| SCHEMBL986360 | 0.82 | NFKB1 (0.47) | ODC1NFKB1DNM1CA12CA2 | |
| SCHEMBL22019599 | 0.82 | ODC1 (0.41) | ODC1NFKB1DNM1CA12CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110198966-A | N- hydroxyethyl piperidine (NHEP): the new curing agent for epoxy systems | 赢创德固赛有限公司 | 2019-09-03 | — | — | CN | claimed |
| US-11542225-B2 | Lipids for use in lipid nanoparticle formulations | Acuitas Therapeutics, Inc. (CA) | 2023-01-03 | — | — | US | disclosed |
| US-20210122702-A1 | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS | Acuitas Therapeutics, Inc. (CA) | 2021-04-29 | — | — | US | disclosed |
| CN-103140605-B | Zinc-based metal plated steel sheet | JFE STEEL CORP. (JP) | 2015-09-02 | — | — | CN | disclosed |
| CN-103140605-A | Galvanized steel sheet | JFE STEEL CORP | 2013-06-05 | — | — | CN | disclosed |
| CN-100374618-C | Surface-treated steel sheet having excellent white rust resistance and method for producing same | NIPPON KOKAN KK KANKI COATING (JP) | 2008-03-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210122702-A1 | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS | LIPC, LIPA, PHOSPHO1 | ODC1 4819/4885NFKB1 1605/4885DNM1 1081/4885 |
| US-11542225-B2 | Lipids for use in lipid nanoparticle formulations | LIPC, LIPA, PHOSPHO1 | ODC1 4819/4885NFKB1 1605/4885DNM1 1081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.